AxoGen Return on Tangible Equity 2010-2025 | AXGN

Current and historical return on tangible equity values for AxoGen (AXGN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
AxoGen Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.01B $0.10B -8.38%
2024-12-31 $-0.01B $0.10B -11.86%
2024-09-30 $-0.02B $0.09B -16.48%
2024-06-30 $-0.02B $0.09B -18.68%
2024-03-31 $-0.02B $0.09B -24.04%
2023-12-31 $-0.02B $0.09B -23.66%
2023-09-30 $-0.02B $0.09B -24.34%
2023-06-30 $-0.02B $0.09B -24.08%
2023-03-31 $-0.02B $0.09B -24.81%
2022-12-31 $-0.03B $0.10B -28.43%
2022-09-30 $-0.03B $0.10B -27.52%
2022-06-30 $-0.03B $0.10B -29.38%
2022-03-31 $-0.03B $0.10B -28.18%
2021-12-31 $-0.03B $0.11B -23.68%
2021-09-30 $-0.03B $0.11B -23.98%
2021-06-30 $-0.02B $0.12B -18.57%
2021-03-31 $-0.02B $0.12B -18.49%
2020-12-31 $-0.02B $0.12B -19.09%
2020-09-30 $-0.02B $0.12B -19.51%
2020-06-30 $-0.03B $0.12B -22.92%
2020-03-31 $-0.03B $0.12B -21.33%
2019-12-31 $-0.03B $0.13B -22.14%
2019-09-30 $-0.03B $0.13B -20.11%
2019-06-30 $-0.03B $0.14B -18.21%
2019-03-31 $-0.03B $0.14B -17.84%
2018-12-31 $-0.02B $0.15B -18.97%
2018-09-30 $-0.02B $0.15B -22.22%
2018-06-30 $-0.02B $0.15B -33.33%
2018-03-31 $-0.01B $0.02B -73.85%
2017-12-31 $-0.01B $0.02B -72.73%
2017-09-30 $-0.01B $0.01B -124.44%
2017-06-30 $-0.01B $0.01B -160.00%
2017-03-31 $-0.02B $0.01B -222.22%
2016-12-31 $-0.02B $0.01B -300.00%
2016-09-30 $-0.01B $0.00B -371.43%
2016-06-30 $-0.01B $0.00B -224.00%
2016-03-31 $-0.01B $0.00B -294.74%
2015-12-31 $-0.01B $0.01B -400.00%
2015-09-30 $-0.02B $0.01B 1066.67%
2015-06-30 $-0.02B $0.00B 228.57%
2015-03-31 $-0.02B $0.00B 212.50%
2014-12-31 $-0.02B $-0.01B 194.29%
2014-09-30 $-0.02B $-0.01B 260.87%
2014-06-30 $-0.02B $-0.01B 800.00%
2014-03-31 $-0.02B $0.00B 600.00%
2013-12-31 $-0.01B $0.00B 430.77%
2013-09-30 $-0.01B $0.00B 350.00%
2013-06-30 $-0.01B $-0.01B 240.00%
2013-03-31 $-0.01B $-0.01B 500.00%
2012-12-31 $-0.01B $0.00B -1800.00%
2012-09-30 $-0.01B $0.00B -280.00%
2012-06-30 $-0.01B $0.00B -188.24%
2012-03-31 $-0.01B $0.00B -133.33%
2011-12-31 $-0.01B $0.01B -114.29%
2011-09-30 $-0.01B $0.01B -288.89%
2011-06-30 $-0.01B $0.01B -209.52%
2011-03-31 $-0.01B $0.01B -180.00%
2010-12-31 $-0.01B $-0.01B -120.00%
2010-09-30 $0.01B $0.01B 130.23%
2010-06-30 $0.02B $0.01B 181.82%
2010-03-31 $0.02B $0.01B 272.73%
2009-12-31 $0.02B $0.01B 545.45%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.498B $0.187B
AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $195.148B 85.47
Thermo Fisher Scientific (TMO) United States $162.069B 19.60
Edwards Lifesciences (EW) United States $45.045B 29.53
IDEXX Laboratories (IDXX) United States $43.992B 50.56
Alcon (ALC) Switzerland $43.297B 29.26
DexCom (DXCM) United States $32.517B 50.26
IQVIA Holdings (IQV) United States $28.414B 15.91
Mettler-Toledo (MTD) United States $25.128B 29.88
STERIS (STE) Ireland $23.368B 25.74
Waters (WAT) United States $20.841B 29.41
SONOVA HOLDING (SONVY) Switzerland $17.678B 0.00
Hologic (HOLX) United States $14.436B 15.69
Sysmex ADR (SSMXY) Japan $10.859B 30.80
Penumbra (PEN) United States $9.723B 76.31
Masimo (MASI) United States $9.086B 33.51
Globus Medical (GMED) United States $8.010B 19.09
Glaukos (GKOS) United States $5.914B 0.00
Teleflex (TFX) United States $5.298B 8.75
TransMedics (TMDX) United States $4.370B 94.99
Integer Holdings (ITGR) United States $4.222B 22.12
PROCEPT BioRobotics (PRCT) United States $3.205B 0.00
LivaNova (LIVN) United Kingdom $2.515B 14.98
Nihon Kohden (NHNKY) Japan $2.346B 26.90
Veracyte (VCYT) United States $2.154B 30.23
Elekta AB (EKTAY) Sweden $1.991B 17.90
Alphatec Holdings (ATEC) United States $1.606B 0.00
Artivion (AORT) United States $1.312B 122.88
Tandem Diabetes Care (TNDM) United States $1.118B 0.00
OPKO Health (OPK) United States $1.079B 0.00
Integra LifeSciences Holdings (IART) United States $1.048B 5.57
Pulse Biosciences (PLSE) United States $1.029B 0.00
SiBone (SIBN) United States $0.787B 0.00
IRadimed (IRMD) United States $0.786B 39.87
Beta Bionics (BBNX) United States $0.586B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.571B 8.88
Mesa Laboratories (MLAB) United States $0.564B 13.22
OrthoPediatrics (KIDS) United States $0.546B 0.00
RxSight (RXST) United States $0.530B 0.00
Pacific Biosciences Of California (PACB) United States $0.480B 0.00
Semler Scientific (SMLR) United States $0.451B 12.00
Delcath Systems (DCTH) United States $0.442B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.436B 0.00
AngioDynamics (ANGO) United States $0.389B 0.00
Treace Medical Concepts (TMCI) United States $0.389B 0.00
NeuroPace (NPCE) United States $0.341B 0.00
ClearPoint Neuro (CLPT) United States $0.327B 0.00
Biosig Technologies (BSGM) United States $0.284B 0.00
Alpha Tau Medical (DRTS) Israel $0.269B 0.00
908 Devices (MASS) United States $0.238B 0.00
Tactile Systems Technology (TCMD) United States $0.236B 14.27
Neuronetics (STIM) United States $0.224B 0.00
Sight Sciences (SGHT) United States $0.218B 0.00
Inogen (INGN) United States $0.201B 0.00
CVRx (CVRX) United States $0.172B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
Rapid Micro Biosystems (RPID) United States $0.159B 0.00
LENSAR (LNSR) United States $0.155B 0.00
Accuray (ARAY) United States $0.146B 0.00
Anteris Technologies Global (AVR) Australia $0.137B 0.00
Lucid Diagnostics (LUCD) United States $0.111B 0.00
Atossa Genetics (ATOS) United States $0.110B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Microbot Medical (MBOT) United States $0.095B 0.00
Sensus Healthcare (SRTS) United States $0.077B 46.60
EnVVeno Medical (NVNO) United States $0.070B 0.00
InspireMD (NSPR) United States $0.069B 0.00
Spectral AI (MDAI) United States $0.068B 0.00
Hyperfine (HYPR) United States $0.062B 0.00
EDAP TMS S.A (EDAP) France $0.059B 0.00
Covalon Technologies (CVALF) Canada $0.052B 21.11
Vicarious Surgical (RBOT) United States $0.045B 0.00
Precision Optics (POCI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.026B 0.00
Adagio Medical Holdings (ADGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.020B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
PAVmed (PAVM) United States $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Ekso Bionics Holdings (EKSO) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.07